Limerick’s angioplasty success
A novel technology invented by researchers at the University of Limerick (UL) will improve success rates in angioplasty procedures. During angioplasty, particles of the fatty deposits can become dislodged and enter the blood stream, which can block other arteries resulting in strokes or heart attacks. Embolic protection devices are often used to capture and remove the dislodged fatty deposits. The UL device combines angioplasty balloon and embolic protection technologies allowing for continuous blood flow during the procedure.
Dr Michael Walsh, University of Limerick; and Ray Blowick, CEO of Clada Medical
Dr Michael Walsh, principal investigator and lead inventor explained, "In practice, this means the angioplasty balloon can be left in a full inflated state in the artery for a longer period of time than is currently possible. This will increase the efficiency of the angioplasty procedure and offers significant potential as a platform for drug–device combinations.” The device has been licensed to Irish-owned Clada Medical. The research was funded by Enterprise Ireland and undertaken at the Centre for Applied Biomedical Engineering Research based in the University’s Materials and Surface Science Institute. www.ul.ie